Louis G. Lange, Director at NewAmsterdam Pharma Co N.V. (NAMS), bought 5,000 shares at $19.00 ($95K) on 2024-02-13, disclosed to the SEC on 2024-02-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |
| BOLD | SELL | 2019-06-26 | $1.5M | — | Filing → |